SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-042887
Filing Date
2018-08-08
Accepted
2018-08-08 17:09:35
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499157_10q.htm 10-Q 355328
2 EXHIBIT 31.1 tv499157_ex31-1.htm EX-31.1 10759
3 EXHIBIT 32.1 tv499157_ex32-1.htm EX-32.1 4370
4 GRAPHIC tv499157_img01.jpg GRAPHIC 31878
  Complete submission text file 0001144204-18-042887.txt   5239265

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT syn-20180630.xml EX-101.INS 1722476
6 XBRL TAXONOMY EXTENSION SCHEMA syn-20180630.xsd EX-101.SCH 34270
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20180630_cal.xml EX-101.CAL 32017
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20180630_def.xml EX-101.DEF 214806
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20180630_lab.xml EX-101.LAB 253275
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20180630_pre.xml EX-101.PRE 246181
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 181002327
SIC: 2834 Pharmaceutical Preparations